Dec 14, 2020 07:20AM

Nov 23, 2020 07:00AM

Nov 19, 2020 07:00AM

Nov 3, 2020 07:30AM

Oct 27, 2020 07:28AM

Oct 8, 2020 07:30AM

Sep 29, 2020 09:10AM ImmunoPrecise Reports Revenue of $3.8 Million and Adjusted EBITDA of $932,000 for the First Quarter of Fiscal 2021

Sep 28, 2020 11:59AM

Sep 25, 2020 07:30AM

Sep 22, 2020 07:30AM

Sep 17, 2020 07:30AM

Sep 10, 2020 07:30AM

Sep 9, 2020 05:37PM

Aug 31, 2020 10:30AM ImmunoPrecise to Present at The LD 500 Virtual Investor Conference

Aug 31, 2020 07:30AM

Jul 31, 2020 08:13AM

Jul 13, 2020 07:51AM

Jun 29, 2020 12:48PM

Jun 11, 2020 08:12AM

Jun 4, 2020 07:30AM

May 27, 2020 07:30AM NSERC Awards Grant to Fund Collaboration Between ImmunoPrecise and the University of Victoria for the Generation of a Potential COVID-19 Antibody-Based Test in Canada that can Provide Real-Time Respon

Apr 17, 2020 08:00AM

Apr 14, 2020 07:00AM

Mar 30, 2020 04:12PM

Mar 12, 2020 07:00AM

Mar 2, 2020 07:00AM

Feb 20, 2020 02:39PM

Nov 5, 2019 04:02PM Talem Therapeutics accesses the OmniAb® platform from Ligand Pharmaceuticals

Sep 24, 2019 08:45AM

Apr 25, 2019 08:30AM

Apr 6, 2018 08:30AM

Dec 7, 2017 08:30AM

1,218,634 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All